早漏症(PE)治療薬の世界市場2016-2020

◆英語タイトル:Global Premature Ejaculation Treatment Market 2016-2020
◆商品コード:IRTNTR9840
◆発行会社(調査会社):Technavio
◆発行日:2016年8月5日
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、早漏症(PE)治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、早漏症(PE)治療薬の世界市場規模及び予測、作用機序別分析、投与経路(ROA)別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Premature Ejaculation
Premature ejaculation refers to the discharge of semen shortly before or after penetration during sexual intercourse, thereby leading to an unsatisfactory sex life and affecting the patient’s relationship with their partner. There is no proper cause that can be associated with the condition. However, personal distress and anxiety are possible attributes.

Technavio’s analysts forecast the global premature ejaculation treatment market to grow at a CAGR of 9.65% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of premature ejaculation drugs and premature ejaculation solutions.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report Global Premature Ejaculation Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Absorption Pharmaceuticals
• Allergan
• Innovus Pharmaceuticals
• Plethora

[Other prominent vendors]
• Aytu BioScience
• Bayer
• Dong-A Pharmaceutical
• Eli Lilly
• Emcure
• Futura Medical
• GlaxoSmithKline
• NeuroHealing Pharmaceuticals
• Pfizer

[Market driver]
• Rise in number of erectile dysfunction cases
• For a full, detailed list, view our report

[Market challenge]
• Threat of alternative treatments
• For a full, detailed list, view our report

[Market trend]
• Increase in awareness of premature ejaculation
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Vendor segmentation
• Key notes
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Geographical segmentation
• Market overview
• Premature ejaculation treatment market in Americas
• Premature ejaculation treatment market in EMEA
• Premature ejaculation treatment market in APAC

PART 07: Market segmentation by route of administration
• Market overview
• Global premature ejaculation treatment market by oral administration
• Global premature ejaculation by topical administration market

PART 08: Market segmentation by mechanism of action
• Premature ejaculation treatment market by mechanism of action

PART 09: Market segmentation by off-label drugs
• Market segmentation by off-label drugs

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape
• Competitive scenario
• Other prominent vendors

PART 16: Key vendor analysis
• Absorption Pharmaceuticals
• Allergan
• Innovus Pharmaceuticals
• Plethora

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Key countries
Exhibit 02: Global premature ejaculation treatment market segmentation: Overview
Exhibit 03: Premature ejaculation prevalence rate for the age group 18-59 by country 2014
Exhibit 04: Premature ejaculation solutions
Exhibit 05: Severity levels of premature ejaculation
Exhibit 06: Clinical diagnosis of premature ejaculation
Exhibit 07: Key product profiles
Exhibit 08: Global premature ejaculation treatment market 2015-2020 ($ billions)
Exhibit 09: Five forces analysis
Exhibit 10: Global premature ejaculation treatment market segmentation by geography 2015-2020
Exhibit 11: Premature ejaculation treatment market in Americas 2015-2020 ($ millions)
Exhibit 12: Types of anxiety affecting adults in US
Exhibit 13: Prevalence rate of premature ejaculation by age group in US
Exhibit 14: Premature ejaculation treatment market in EMEA 2015-2020 ($ millions)
Exhibit 15: Premature ejaculation treatment market in APAC 2015-2020 ($ millions)
Exhibit 16: Number of internet users in APAC countries 2016 (millions)
Exhibit 17: Global premature ejaculation treatment market segmentation by route of administration 2015 and 2020
Exhibit 18: Global premature ejaculation treatment market segmentation by share 2015-2020
Exhibit 19: Global premature ejaculation treatment market by oral administration 2015-2020 ($ billions)
Exhibit 20: Global premature ejaculation treatment market segmentation by topical administration 2015-2020 ($ millions)
Exhibit 21: Market share by mechanism of action 2015-2020
Exhibit 22: Key SSRIs and NSRIs
Exhibit 23: Off-label premature ejaculation drugs market share
Exhibit 24: Impact of drivers
Exhibit 25: Premature ejaculation treatments in pipeline and their side effects
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Internet use by region 2015
Exhibit 28: Absorption: Key takeaways
Exhibit 29: Allergan: Key takeaways
Exhibit 30: Innovus: Key takeaways
Exhibit 31: Plethora: Key takeaways



【掲載企業】

Absorption Pharmaceuticals, Allergan, Innovus Pharmaceuticals, Plethora, Aytu BioScience, Bayer, Dong-A Pharmaceutical, Eli Lilly, Emcure, Futura Medical, GlaxoSmithKline, NeuroHealing Pharmaceuticals, Pfizer.


【レポートのキーワード】

早漏症、早漏症治療薬、医薬品

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[早漏症(PE)治療薬の世界市場2016-2020]販売に関する免責事項
★調査レポート[早漏症(PE)治療薬の世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆